Published in Mol Carcinog on December 01, 1996
Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell (2011) 3.88
Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9. Mol Biol Cell (2008) 1.10
K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma. Am J Pathol (2004) 1.10
Stat1 phosphorylation determines Ras oncogenicity by regulating p27 kip1. PLoS One (2008) 0.95
Rare codons capacitate Kras-driven de novo tumorigenesis. J Clin Invest (2014) 0.95
A mouse model repository for cancer biomarker discovery. J Proteome Res (2008) 0.94
Effects of mutant human Ki-ras(G12C) gene dosage on murine lung tumorigenesis and signaling to its downstream effectors. Toxicol Appl Pharmacol (2008) 0.87
Preclinical Murine Models for Lung Cancer: Clinical Trial Applications. Biomed Res Int (2015) 0.83
Overview of the molecular carcinogenesis of mouse lung tumor models of human lung cancer. Toxicol Pathol (2007) 0.82
A review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer. Toxicol Pathol (2009) 0.81
Oxidative stress-induced 1, N6-ethenodeoxyadenosine adduct formation contributes to hepatocarcinogenesis. Oncol Rep (2013) 0.81
ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model. J Pathol (2012) 0.79
MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation. Oncogene (2017) 0.78
NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling. Oncotarget (2016) 0.78
Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years. Cold Spring Harb Protoc (2015) 0.76
Kras, Egfr, and Tp53 Mutations in B6C3F1/N Mouse and F344/NTac Rat Alveolar/Bronchiolar Carcinomas Resulting from Chronic Inhalation Exposure to Cobalt Metal. Toxicol Pathol (2015) 0.75
BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions in vivo. Oncoscience (2016) 0.75
Immunohistochemical characterization of urethane-induced lung tumors in CB6F1-Tg rasH2 mice. J Toxicol Pathol (2017) 0.75
The Kras2 oncogene and mouse lung carcinogenesis. Med Mol Morphol (2008) 0.75
Artemis: sequence visualization and annotation. Bioinformatics (2000) 46.68
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60
Changes in forest biomass carbon storage in China between 1949 and 1998. Science (2001) 7.39
Automated DNA sequencing of the human HPRT locus. Genomics (1990) 5.92
Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A (1991) 5.78
VT/VF: 60/60 protection. Pacing Clin Electrophysiol (1990) 5.15
Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature (1998) 4.97
Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice. J Natl Cancer Inst (1983) 4.72
Uptake of immunisation in district health authorities in England. Br Med J (Clin Res Ed) (1988) 4.37
Distribution of NHS funds between fundholding and non-fundholding practices. BMJ (1994) 4.05
SOAP-based services provided by the European Bioinformatics Institute. Nucleic Acids Res (2005) 3.93
Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet (1998) 3.89
The PH domain: a common piece in the structural patchwork of signalling proteins. Trends Biochem Sci (1993) 3.89
Factors affecting quality of informed consent. BMJ (1993) 3.68
Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol Cell (1999) 3.58
The selectins: vascular adhesion molecules. FASEB J (1995) 3.45
Cripto is required for correct orientation of the anterior-posterior axis in the mouse embryo. Nature (1998) 3.16
Teenagers' health concerns: implications for primary health care professionals. J R Coll Gen Pract (1989) 3.00
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A (1995) 2.99
An open label study of the effects of rituximab in neuromyelitis optica. Neurology (2005) 2.99
Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol (1995) 2.90
Reactive pseudosarcomatous response in urinary bladder. Urology (1980) 2.89
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg (2000) 2.88
Tay-sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay. N Engl J Med (1970) 2.75
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol (1995) 2.62
Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res (1999) 2.54
Conjugation of Nedd8 to CUL1 enhances the ability of the ROC1-CUL1 complex to promote ubiquitin polymerization. J Biol Chem (2000) 2.53
Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52
Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J Biol Chem (1994) 2.46
A semi-automated method for the reading of nucleic acid sequencing gels. Nucleic Acids Res (1982) 2.44
Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet (2001) 2.34
Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc Natl Acad Sci U S A (2001) 2.29
Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg (1995) 2.25
A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25
Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control (2001) 2.10
Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis (2003) 2.09
HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin. Oncogene (1999) 2.05
The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E. J Mol Biol (2001) 2.05
Survival in early-stage non-small cell lung cancer. Ann Thorac Surg (1995) 2.01
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med (1983) 1.99
Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.97
Kainate receptor-mediated heterosynaptic facilitation in the amygdala. Nat Neurosci (2001) 1.96
Radiation therapy following resection of non-small cell bronchogenic carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.93
Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol Cell Biol (2000) 1.93
Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res (2001) 1.91
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis (2010) 1.90
Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene (2010) 1.87
NY-ESO-1 may be a potential target for lung cancer immunotherapy. Cancer J Sci Am (1999) 1.86
Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J Natl Cancer Inst (1994) 1.83
Central visual field in diabetes. Br J Ophthalmol (1969) 1.83
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg (2000) 1.83
Specificity, stereochemistry, and mechanism of the color reaction between p-dimethylaminocinnamalhyde and biotin analogs. Anal Biochem (1970) 1.82
Energy landscape of streptavidin-biotin complexes measured by atomic force microscopy. Biochemistry (2000) 1.81
Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res (1999) 1.78
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. Ann Surg Oncol (1998) 1.78
Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem (2001) 1.77
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol (1998) 1.76
Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom. J Clin Microbiol (2001) 1.75
Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet (1998) 1.75
The use of the GlideScope for tracheal intubation in patients with ankylosing spondylitis. Br J Anaesth (2006) 1.74
Compilation of DNA sequences of Escherichia coli (update 1991). Nucleic Acids Res (1991) 1.73
Calpain activation in apoptosis. J Cell Physiol (1994) 1.72
Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem (1997) 1.68
The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation. Mol Cell Biol (2000) 1.67
Surfactant protein C expression in urethane-induced murine pulmonary tumors. Am J Pathol (2000) 1.64
Neutrophil activation by recombinant cytokines. Rev Infect Dis (1989) 1.63
Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg (1997) 1.62
Midazolam vs ondansetron for preventing postoperative nausea and vomiting: a randomised controlled trial. Anaesthesia (2007) 1.60
Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest (1992) 1.59
Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res (1994) 1.59
The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII. Nature (1997) 1.59
Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood (1995) 1.58
Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Mol Psychiatry (2009) 1.57
The nucleotide sequence of Saccharomyces cerevisiae chromosome IX. Nature (1997) 1.56
Excessive use of force by police: a survey of academic emergency physicians. Emerg Med J (2009) 1.56
Reasons for outpatient referrals from generalists to specialists. J Gen Intern Med (1999) 1.55
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst (2001) 1.55
Amphetamine toxicity: experience with 127 cases. J Emerg Med (1989) 1.53
The Akt proto-oncogene links Ras to Pak and cell survival signals. J Biol Chem (2000) 1.53
Benefits of implantable defibrillators are overestimated by sudden death rates and better represented by the total arrhythmic death rate. J Am Coll Cardiol (1991) 1.53
In vivo investigation of blood compatibility of titanium oxide films. J Biomed Mater Res (1998) 1.53
Compilation of DNA sequences of Escherichia coli (update 1992). Nucleic Acids Res (1992) 1.52
Antigenic heterogeneity of lipid A of Haemophilus influenzae. Infect Immun (1985) 1.50
Statistical evaluation and biological interpretation of non-random abundance in the E. coli K-12 genome of tetra- and pentanucleotide sequences related to VSP DNA mismatch repair. Nucleic Acids Res (1992) 1.50
Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thorac Surg (1992) 1.49
Cooperativity mutants of the gamma delta resolvase identify an essential interdimer interaction. Cell (1990) 1.49
Synovial sarcoma of the neck: a followup study of 24 cases. Cancer (1975) 1.48
p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res (1991) 1.48
Alpha-helix stabilization by natural and unnatural amino acids with alkyl side chains. Proc Natl Acad Sci U S A (1991) 1.48
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst (1999) 1.47
The role of AHA motifs in the activator function of tomato heat stress transcription factors HsfA1 and HsfA2. Plant Cell (2000) 1.46
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis (2001) 1.46
Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinog (2000) 1.45
Routine use of unilateral and bilateral radial arteries for coronary artery bypass graft surgery. J Am Coll Cardiol (1996) 1.45
Cells of origin of primary pulmonary neoplasms in mice: morphologic and histochemical studies. Exp Lung Res (1991) 1.44